Echo IQ Says EchoSolv AS Software Usage Up Around 131%

MT Newswires Live04-30

Echo IQ (ASX:EIQ) said the usage of EchoSolv AS, its decision support software for the assessment of severe aortic stenosis, a progressive heart condition, was up around 131% quarter over quarter in the three months ended March 31, according to a Thursday Australian bourse filing.

The company said 9,220 echocardiograms were processed in the first quarter, from 3,992 in the December 2025 quarter.

The company is progressing its heart failure clinical decision support product, EchoSolv HF, through the US Food and Drug Administration 510(k) pathway.

It is also focused on securing major US hospital group signings and advancing regulatory clearance via Australia's Therapeutic Goods Administration, per the filing.

Echo IQ's shares fell nearly 2% in recent trading on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2631940503?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 12:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631940503","market":"sh","top_or_hot":-1,"title":"Echo IQ Says EchoSolv AS Software Usage Up Around 131%","media":"MT Newswires Live","content":"<html><body><p> Echo IQ (ASX:EIQ) said the usage of EchoSolv AS, its decision support software for the assessment of severe aortic stenosis, a progressive heart condition, was up around 131% quarter over quarter in the three months ended March 31, according to a Thursday Australian bourse filing.</p><p>The company said 9,220 echocardiograms were processed in the first quarter, from 3,992 in the December 2025 quarter.</p><p>The company is progressing its heart failure clinical decision support product, EchoSolv HF, through the US Food and Drug Administration 510(k) pathway.</p><p>It is also focused on securing major US hospital group signings and advancing regulatory clearance via Australia's Therapeutic Goods Administration, per the filing.</p><p>Echo IQ's shares fell nearly 2% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Echo IQ Says EchoSolv AS Software Usage Up Around 131%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEcho IQ Says EchoSolv AS Software Usage Up Around 131%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-30 12:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Echo IQ (ASX:EIQ) said the usage of EchoSolv AS, its decision support software for the assessment of severe aortic stenosis, a progressive heart condition, was up around 131% quarter over quarter in the three months ended March 31, according to a Thursday Australian bourse filing.</p><p>The company said 9,220 echocardiograms were processed in the first quarter, from 3,992 in the December 2025 quarter.</p><p>The company is progressing its heart failure clinical decision support product, EchoSolv HF, through the US Food and Drug Administration 510(k) pathway.</p><p>It is also focused on securing major US hospital group signings and advancing regulatory clearance via Australia's Therapeutic Goods Administration, per the filing.</p><p>Echo IQ's shares fell nearly 2% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EIQ.AU","symbol_name":"ECHOIQ LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2631940503","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631940503","pubTimestamp":1777523204,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Echo IQ  said the usage of EchoSolv AS, its decision support software for the assessment of severe aortic stenosis, a progressive heart condition, was up around 131% quarter over quarter in the three months ended March 31, according to a Thursday Australian bourse filing.The company said 9,220 echocardiograms were processed in the first quarter, from 3,992 in the December 2025 quarter.The company is progressing its heart failure clinical decision support product, EchoSolv HF, through the US Food and Drug Administration 510 pathway.It is also focused on securing major US hospital group signings and advancing regulatory clearance via Australia's Therapeutic Goods Administration, per the filing.Echo IQ's shares fell nearly 2% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EIQ.AU":"ECHOIQ LTD","BK4552":"Archegos爆仓风波概念","BK4108":"电影和娱乐","IQ":"爱奇艺","BK4531":"中概回港概念","BK7016":"应用软件","BK4526":"热门中概股","BK4505":"高瓴资本持仓"},"translate_title":"Echo IQ表示EchoSolv软件使用量增长约131%","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EIQ.AU":1,"IQ":1.5},"content_text":"Echo IQ (ASX:EIQ) said the usage of EchoSolv AS, its decision support software for the assessment of severe aortic stenosis, a progressive heart condition, was up around 131% quarter over quarter in the three months ended March 31, according to a Thursday Australian bourse filing.The company said 9,220 echocardiograms were processed in the first quarter, from 3,992 in the December 2025 quarter.The company is progressing its heart failure clinical decision support product, EchoSolv HF, through the US Food and Drug Administration 510(k) pathway.It is also focused on securing major US hospital group signings and advancing regulatory clearance via Australia's Therapeutic Goods Administration, per the filing.Echo IQ's shares fell nearly 2% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2631940503","isCrawlerRequest":true}